Analysts think CORT stock price could increase by 285%
Jan 07, 2026, 12:25 PM
29.36%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
7 analysts think CORT stock price will increase by 285.23%. The current median analyst target is $137.70 compared to a current stock price of $35.74. The lowest analysts target is $95.95 and the highest analyst target is $152.15.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.